Suppr超能文献

帕金森病中 EIF4G1 和 VPS35 稀有变异的全外显子组测序。

Whole exome sequencing of rare variants in EIF4G1 and VPS35 in Parkinson disease.

机构信息

John P. Hussman Institute for Human Genomics, Miller School of Medicine, University of Miami, FL, USA.

出版信息

Neurology. 2013 Mar 12;80(11):982-9. doi: 10.1212/WNL.0b013e31828727d4. Epub 2013 Feb 13.

Abstract

OBJECTIVE

Recently, vacuolar protein sorting 35 (VPS35) and eukaryotic translation initiation factor 4 gamma 1 (EIF4G1) have been identified as 2 causal Parkinson disease (PD) genes. We used whole exome sequencing for rapid, parallel analysis of variations in these 2 genes.

METHODS

We performed whole exome sequencing in 213 patients with PD and 272 control individuals. Those rare variants (RVs) with <5% frequency in the exome variant server database and our own control data were considered for analysis. We performed joint gene-based tests for association using RVASSOC and SKAT (Sequence Kernel Association Test) as well as single-variant test statistics.

RESULTS

We identified 3 novel VPS35 variations that changed the coded amino acid (nonsynonymous) in 3 cases. Two variations were in multiplex families and neither segregated with PD. In EIF4G1, we identified 11 (9 nonsynonymous and 2 small indels) RVs including the reported pathogenic mutation p.R1205H, which segregated in all affected members of a large family, but also in 1 unaffected 86-year-old family member. Two additional RVs were found in isolated patients only. Whereas initial association studies suggested an association (p = 0.04) with all RVs in EIF4G1, subsequent testing in a second dataset for the driving variant (p.F1461) suggested no association between RVs in the gene and PD.

CONCLUSIONS

We confirm that the specific EIF4G1 variation p.R1205H seems to be a strong PD risk factor, but is nonpenetrant in at least one 86-year-old. A few other select RVs in both genes could not be ruled out as causal. However, there was no evidence for an overall contribution of genetic variability in VPS35 or EIF4G1 to PD development in our dataset.

摘要

目的

最近,液泡分选蛋白 35(VPS35)和真核翻译起始因子 4 伽马 1(EIF4G1)已被确定为 2 个导致帕金森病(PD)的基因。我们使用全外显子组测序快速平行分析这 2 个基因的变异。

方法

我们对 213 名 PD 患者和 272 名对照个体进行了全外显子组测序。那些在 Exome Variant Server 数据库和我们自己的对照数据中频率小于 5%的罕见变异(RVs)被认为是分析对象。我们使用 RVASSOC 和 SKAT(序列核关联测试)进行联合基因关联测试,并使用单变异测试统计量进行分析。

结果

我们发现了 3 种新的 VPS35 变异,它们改变了 3 例患者的编码氨基酸(非同义)。2 种变异存在于多灶性家族中,均与 PD 无关。在 EIF4G1 中,我们发现了 11 种(9 种非同义突变和 2 种小插入缺失)RVs,包括报道的致病性突变 p.R1205H,它在一个大家族的所有受影响成员中都存在,而在一个 86 岁的未受影响的家族成员中也存在。另外 2 种 RVs仅在孤立患者中发现。尽管最初的关联研究表明 EIF4G1 中的所有 RVs 都与 PD 相关(p=0.04),但随后在第二个数据集对驱动变异(p.F1461)进行的测试表明,基因中的 RVs 与 PD 之间没有关联。

结论

我们证实特定的 EIF4G1 变异 p.R1205H 似乎是一个很强的 PD 风险因素,但至少在一位 86 岁的患者中并不具有穿透性。这两个基因中的其他一些选择性 RVs 也不能排除为因果关系。然而,在我们的数据集没有证据表明 VPS35 或 EIF4G1 中的遗传变异总体上对 PD 的发展有贡献。

相似文献

1
Whole exome sequencing of rare variants in EIF4G1 and VPS35 in Parkinson disease.
Neurology. 2013 Mar 12;80(11):982-9. doi: 10.1212/WNL.0b013e31828727d4. Epub 2013 Feb 13.
2
D620N mutation in the VPS35 gene and R1205H mutation in the EIF4G1 gene are uncommon in the Greek population.
Neurosci Lett. 2015 Oct 8;606:113-6. doi: 10.1016/j.neulet.2015.08.020. Epub 2015 Aug 20.
3
VPS35 and EIF4G1 mutations are rare in Parkinson's disease among Indians.
Neurobiol Aging. 2013 Oct;34(10):2442.e1-3. doi: 10.1016/j.neurobiolaging.2013.04.025. Epub 2013 May 28.
4
VPS35 Asp620Asn and EIF4G1 Arg1205His mutations are rare in Parkinson disease from southwest China.
Neurobiol Aging. 2013 Jun;34(6):1709.e7-8. doi: 10.1016/j.neurobiolaging.2012.11.003. Epub 2012 Dec 20.
5
Analysis of EIF4G1 in ethnic Chinese.
BMC Neurol. 2013 Apr 26;13:38. doi: 10.1186/1471-2377-13-38.
6
Frequency of the ASP620ASN mutation in VPS35 and Arg1205His mutation in EIF4G1 in familial Parkinson's disease from South Italy.
Neurobiol Aging. 2014 Oct;35(10):2422.e1-2. doi: 10.1016/j.neurobiolaging.2014.04.020. Epub 2014 Apr 26.
7
EIF4G1 R1205H and VPS35 D620N mutations are rare in Parkinson's disease from South Africa.
Neurobiol Aging. 2014 Feb;35(2):445.e1-3. doi: 10.1016/j.neurobiolaging.2013.08.023. Epub 2013 Sep 27.
8
Study of the genetic variability in a Parkinson's Disease gene: EIF4G1.
Neurosci Lett. 2012 Jun 14;518(1):19-22. doi: 10.1016/j.neulet.2012.04.033. Epub 2012 Apr 23.
9
EIF4G1 is neither a strong nor a common risk factor for Parkinson's disease: evidence from large European cohorts.
J Med Genet. 2015 Jan;52(1):37-41. doi: 10.1136/jmedgenet-2014-102570. Epub 2014 Nov 3.
10
VPS35 and EIF4G1 interactions and novel candidate genes for PD: from genes to pathways and back.
Mov Disord. 2015 Apr;30(4):499. doi: 10.1002/mds.26187. Epub 2015 Mar 15.

引用本文的文献

1
A Next-Generation Sequencing Study in a Cohort of Sicilian Patients with Parkinson's Disease.
Biomedicines. 2023 Nov 22;11(12):3118. doi: 10.3390/biomedicines11123118.
2
VPS35, the core component of the retromer complex, and Parkinson's disease.
Ibrain. 2021 Dec 9;7(4):318-324. doi: 10.1002/ibra.12004. eCollection 2021 Winter.
3
Association study of DNAJC13, UCHL1, HTRA2, GIGYF2, and EIF4G1 with Parkinson's disease.
Neurobiol Aging. 2021 Apr;100:119.e7-119.e13. doi: 10.1016/j.neurobiolaging.2020.10.019. Epub 2020 Oct 31.
4
Unveiling the cryo-EM structure of retromer.
Biochem Soc Trans. 2020 Oct 30;48(5):2261-2272. doi: 10.1042/BST20200552.
5
The Role of VPS35 in the Pathobiology of Parkinson's Disease.
Cell Mol Neurobiol. 2021 Mar;41(2):199-227. doi: 10.1007/s10571-020-00849-8. Epub 2020 Apr 22.
6
Golgi Complex Dynamics and Its Implication in Prevalent Neurological Disorders.
Front Cell Dev Biol. 2019 May 7;7:75. doi: 10.3389/fcell.2019.00075. eCollection 2019.
7
8
Molecular targets for modulating the protein translation vital to proteostasis and neuron degeneration in Parkinson's disease.
Transl Neurodegener. 2019 Feb 4;8:6. doi: 10.1186/s40035-019-0145-0. eCollection 2019.
9
Advances in the Genetics of Parkinson's Disease: A Guide for the Clinician.
Mov Disord Clin Pract. 2014 Apr 10;1(1):3-13. doi: 10.1002/mdc3.12000. eCollection 2014 Apr.

本文引用的文献

1
Variants in eukaryotic translation initiation factor 4G1 in sporadic Parkinson's disease.
Neurogenetics. 2012 Aug;13(3):281-5. doi: 10.1007/s10048-012-0334-9. Epub 2012 Jun 16.
2
VPS35 gene variants are not associated with Parkinson's disease in the mainland Chinese population.
Parkinsonism Relat Disord. 2012 Sep;18(8):983-5. doi: 10.1016/j.parkreldis.2012.05.002. Epub 2012 Jun 4.
3
Study of the genetic variability in a Parkinson's Disease gene: EIF4G1.
Neurosci Lett. 2012 Jun 14;518(1):19-22. doi: 10.1016/j.neulet.2012.04.033. Epub 2012 Apr 23.
4
Identification of VPS35 mutations replicated in French families with Parkinson disease.
Neurology. 2012 May 1;78(18):1449-50. doi: 10.1212/WNL.0b013e318253d5f2. Epub 2012 Apr 18.
6
Contribution of VPS35 genetic variability to LBD in the Flanders-Belgian population.
Neurobiol Aging. 2012 Aug;33(8):1844.e11-3. doi: 10.1016/j.neurobiolaging.2012.01.006. Epub 2012 Feb 14.
7
Screening for VPS35 mutations in Parkinson's disease.
Neurobiol Aging. 2012 Apr;33(4):838.e1-5. doi: 10.1016/j.neurobiolaging.2011.10.032. Epub 2011 Dec 7.
8
Translation initiator EIF4G1 mutations in familial Parkinson disease.
Am J Hum Genet. 2011 Sep 9;89(3):398-406. doi: 10.1016/j.ajhg.2011.08.009.
9
A mutation in VPS35, encoding a subunit of the retromer complex, causes late-onset Parkinson disease.
Am J Hum Genet. 2011 Jul 15;89(1):168-75. doi: 10.1016/j.ajhg.2011.06.008.
10
VPS35 mutations in Parkinson disease.
Am J Hum Genet. 2011 Jul 15;89(1):162-7. doi: 10.1016/j.ajhg.2011.06.001.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验